Survival of very premature infants is improving in France: First results of the EPIPAGE 2 study

25 February 2015

Since 2011, nearly 7,000 premature infants have been enrolled in the EPIPAGE 2 study. This study is aimed at assessing the survival of infants born between 22 and 34 weeks’ gestation, and their subsequent outcomes. Compared with data from the EPIPAGE 1 cohort in 1997, the proportion of infants born in 2011 from the 25th week of gestation, who survived without severe neonatal disease, showed a definite increase. However, survival is still rare for infants born before 25 weeks. These results make it possible to establish the prognosis for very premature and extremely premature infants, and review the changes that have occurred in the last 15 years. They provide useful information to medical teams caring for infants and supporting families.

This study, carried out by researchers from the Inserm EPOPé team—“Obstetrical, Perinatal, and Pediatric Epidemiology Team,” at the Epidemiology and Biostatistics Sorbonne Paris Cité Research Centre (CRESS, Inserm/Paris Descartes University Unit 1153)—is published in the journal JAMA Pediatrics.

 

http://presse-inserm.fr/en/survival-of-very-premature-infants-is-improving-in-france-first-results-of-the-epipage-2-study/17643/

ANR: call for European research projects on neurodegenerative diseases

23 February 2015

Concerned neurodegenerative diseases are Alzheimer's disease and other dementias, Parkinson's disease and related diseases, prion diseases, motor neuron disease, Huntington's disease, cerebro-spinal ataxia and spinal muscular atrophy. Submitted projects must demonstrate added value of transnational cooperation and will include three to eight research teams from at least 3 countries participating in the PAA (list on the website of the ANR). Funding will be awarded for a period of three years. The ANR will fund only the French partners of the selected projects.

Deadline for applications: 10 March 2015

 

http://www.agence-nationale-recherche.fr/financer-votre-projet/documents/appel-detail0/appel-a-projets-de-recherche-europeens-sur-les-maladies-neurodegeneratives-facteurs-de-risque-et-de-protection-etudes-longitudinales-sur-cohortes-et-modeles-experimentaux-avances-jpcofund-2015-2015/

Inserm, CPU and 7 research organizations sign a "national code of ethics of research work"

16 February 2015

Inserm, the CPU and 7 research organizations signed a "national code of ethics of research work".

Universities, represented by the CPU (Conference of University Presidents), CNRS, INSERM, INRA, INRIA, IRD, CIRAD and the Institut Curie signed a "code of conduct of research occupations, "on Thursday, January 29, 2015 in Paris, during a seminar dedicated to scientific integrity. Developed by INSERM, the CPU, the CNRS and INRA, the charter aims to "clarify the criteria for good science and incorporates applicable particularly in the context of all national and international partnerships"

iCEPS conference

09 February 2015

iCEPS conference

 

From 19 to 21 March 2015 in Montpellier (France) - Le Corum

Organizer: iCEPS

Thematic: non-drug interventional research

The conference is open to anyone interested in scientific, medical, social, legal and ethical posed by non-drug interventions.

 

Explore the catalog

The catalog contains the description of the main databases in public health in France

Explore the catalog

Become a contributor

You wish to share the information about your database with researchers and experts in public health?

Become a contributor

Contact us

You have a question? You need more information? 

Send a message

Latest publications

See the latest database descriptions publicated on the portail

Go to the publications

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05

View Edit Create here